| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 15.50 | 0.15 (+0.98%) | 11.28 - 15.50 | 0.0 |
Market data as of 6:05PM 05/17/13. Quotes are delayed by at least 15 min.
The investment seeks long-term growth of capital. The fund invests primarily in equity securities of companies located outside the U.S., including in emerging markets. Equity securities include common stocks and preferred stocks. It also invests in American Depositary Receipts (ADRs), European Depositary Receipts (EDRs) and Global Depositary Receipts (GDRs), which are certificates typically issued by a bank or trust company that give their holders the right to receive securities issued by a foreign or domestic company.
| Total Return | 4.27% |
|---|---|
| Yield (Trailing 12 Mo.) | 2.13% |
| Expense Ratio | 0.97% |
| Front Load | None |
| Deferred Load | None |
| Minimum Investment | $0.00 |
| Management Tenure | 8 Years |
| Fund Inception | 10/14/2005 |
| Timeframe | JIVIX | S&P 500 | Foreign Large Value |
|---|---|---|---|
| 1 Month | 4.74% | 1.93% | 4.87% |
| 3 Month | -0.20% | 7.18% | 3.92% |
| Year-to-Date | 4.82% | 12.74% | 8.31% |
| 1 Year | 17.32% | 16.89% | 17.03% |
| 3 Year | 5.97% | 12.80% | 6.02% |
| 5 Year | -0.06% | 5.21% | -1.76% |
| 10 Year | -- | 7.88% | 8.69% |
| Since Inception | 4.27% | 10.38% | -- |
| Basic Materials | 5.63% | |
|---|---|---|
| Consumer Cyclical | 5.88% | |
| Financial Services | 29.14% | |
| Real Estate | 0.00% | |
| Consumer Defensive | 4.27% | |
| Healthcare | 11.61% | |
| Utilities | 0.10% | |
| Communication Services | 8.52% | |
| Energy | 14.80% | |
| Industrials | 11.55% | |
| Technology | 8.50% |
| By Percent | Short | 0% | Long | Net | |
|---|---|---|---|---|---|
| Stock | -- | 0.92 | 0.92 | ||
| Bond | -- | 0.00 | 0.00 | ||
| Other | -- | 0.65 | 0.65 | ||
| Foreign Stock | -- | 95.64 | 95.64 | ||
| Foreign Bond | -- | 0.00 | 0.00 | ||
| Total | -- | 97.21 | 97.21 | ||
| Cash | -- | 2.79 | 2.79 | ||
| Total Net Assets | $1.56B |
|---|---|
| Total Stock Holdings | 88 |
| Total Bond Holdings | 0 |
| Company | YTD Return | % of Assets |
|---|---|---|
| ING Groep N.V. | -- | 3.61% |
| Credit Suisse Group | -- | 3.35% |
| BNP Paribas | -- | 2.93% |
| Sanofi | -- | 2.84% |
| Roche Holding AG | 23.65% | 2.42% |
| AXA SA | 4.00% | 2.26% |
| GlaxoSmithKline PLC | 20.09% | 2.24% |
| Tesco PLC | -- | 2.18% |
| KB | -9.44% | 2.12% |
| Aviva PLC | -- | 2.11% |
| Valuation | JIVIX | Category Range |
|---|---|---|
| Price/Earnings | 12.91 | |
| Price/Book | 1.02 | |
| Price/Sales | 0.54 | |
| Price/Cash Flow | 6.78 | |
| Dividend Yield | 3.45 | |
| LT Earnings | 8.55 | |
| Historical Earnings | 3.26 | |
| Sales Growth | 1.04 | |
| Cash-Flow Growth | -4.03 | |
| Book-Value Growth | 1.66 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
 |  |  |
| Rating | vs Category | |
|---|---|---|
| Overall |  | |
| Risk | Above Avg | |
| Return | Avg |
| Pretax Return | 5.97% |
|---|---|
| Tax-adjusted Return | 5.07% |
| Tax Cost Ratio | 0.85% |
| Potential Cap Gains | -8.48% |
